(CRD-B) Crawford - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2246331076

CRD-B EPS (Earnings per Share)

This chart shows the EPS (Earnings per Share) of CRD-B over the last 5 years for every Quarter.

CRD-B Revenue

This chart shows the Revenue of CRD-B over the last 5 years for every Quarter.

CRD-B: Claims Management, Risk Management, Outsourcing Services

Crawford & Company is a global provider of claims management and outsourcing solutions, serving insurance carriers, brokers, and corporations across multiple regions, including the United States, the United Kingdom, Europe, Canada, Australia, Asia, and Latin America. The companys comprehensive suite of services includes claims management, field investigation, and loss mitigation, as well as risk management information and consultative analytical services.

With a presence in numerous markets, Crawford & Company has established itself as a leading player in the insurance claims management industry. Its services cater to a diverse range of insurance types, including property, casualty, workers compensation, and disability claims. The companys expertise extends to managing complex claims resulting from natural disasters, such as hurricanes and earthquakes, as well as man-made disasters, like oil spills and explosions.

Crawford & Companys business model is built on providing tailored solutions to insurance carriers and self-insured entities, leveraging its expertise in claims management, risk management, and loss mitigation. The companys services are designed to help clients mitigate losses, reduce costs, and improve their overall claims handling efficiency. With a strong presence in the global insurance industry, Crawford & Company is well-positioned to capitalize on emerging trends and opportunities.

Analyzing the , we observe that the stocks last price is $10.30, with a 20-day SMA of $10.28, indicating a slight upward trend. The 50-day and 200-day SMAs are $10.78 and $10.82, respectively, suggesting a potential resistance level around $10.80. The ATR of 0.59 represents a 5.77% volatility, which is relatively moderate. Considering the , the companys market capitalization is approximately $526.14 million, with a P/E ratio of 20.15 and a forward P/E of 12.00. The RoE of 13.60% indicates a relatively stable and profitable business.

Based on the and , our forecast suggests that Crawford & Companys stock may experience a moderate increase in the near term, driven by its stable financial performance and the growing demand for claims management services in the insurance industry. With a target price of $11.50, representing a 11.65% upside from the current price, we believe that the stock has the potential to outperform the market in the coming quarters. However, investors should be cautious of the potential resistance level around $10.80 and the moderate volatility indicated by the ATR.

Additional Sources for CRD-B Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

CRD-B Stock Overview

Market Cap in USD 522m
Sector Financial Services
Industry Insurance Brokers
GiC Sub-Industry Life & Health Insurance
IPO / Inception 1990-01-12

CRD-B Stock Ratings

Growth Rating 40.0
Fundamental 20.1
Dividend Rating 66.0
Rel. Strength -8.27
Analysts 5 of 5
Fair Price Momentum 8.53 USD
Fair Price DCF 24.58 USD

CRD-B Dividends

Dividend Yield 12m 2.79%
Yield on Cost 5y 4.40%
Annual Growth 5y 10.49%
Payout Consistency 82.0%
Payout Ratio 32.2%

CRD-B Growth Ratios

Growth Correlation 3m -47.3%
Growth Correlation 12m 32.1%
Growth Correlation 5y 63.9%
CAGR 5y 8.12%
CAGR/Max DD 5y 0.16
Sharpe Ratio 12m 0.81
Alpha 1.40
Beta 1.181
Volatility 49.30%
Current Volume 13.2k
Average Volume 20d 4.7k
What is the price of CRD-B shares?
As of June 17, 2025, the stock is trading at USD 9.40 with a total of 13,200 shares traded.
Over the past week, the price has changed by -3.98%, over one month by -11.78%, over three months by -11.20% and over the past year by +13.50%.
Is Crawford a good stock to buy?
Neither. Based on ValueRay´s Fundamental Analyses, Crawford is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 20.05 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CRD-B is around 8.53 USD . This means that CRD-B is currently overvalued and has a potential downside of -9.26%.
Is CRD-B a buy, sell or hold?
Crawford has received a consensus analysts rating of 5.00. Therefor, it is recommend to buy CRD-B.
  • Strong Buy: 2
  • Buy: 0
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecasts for CRD-B share price target?
According to our own proprietary Forecast Model, CRD-B Crawford will be worth about 9.5 in June 2026. The stock is currently trading at 9.40. This means that the stock has a potential upside of +1.28%.
Issuer Target Up/Down from current
Wallstreet Target Price 14 48.9%
Analysts Target Price 14 48.9%
ValueRay Target Price 9.5 1.3%